Singapore’s M&L Healthcare Investments has announced the sale of its arterial ischemia treatment technology startup LimFlow, while Japanese mobile operator NTT Docomo has joined a consortium led by Mitsui & Co. to bid for a majority stake in Malaysia’s Edotco Group.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
